SCHEMBL3661720

SCHEMBL3661720

CCCC#CCCOc1cccc(NC)c1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.33
APP P05067 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KMT2A Q03164 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MEN1 O00255 1/20 0.32
HTR1B P28222 3/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2D6 P10635 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PTGS2 P35354 2/20 0.32
HTR1D P28221 1/20 0.31
CYP2C9 P11712 1/20 0.31
ALDH1A1 P00352 2/20 0.31
GAA P10253 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664058 0.93 L3MBTL1 (0.35) PTPN1APPL3MBTL1KMT2ANPC1
SCHEMBL3658303 0.92 PPARG (0.36) PTPN1L3MBTL1KMT2AHTR1BCYP1A2
SCHEMBL3662391 0.91 APP (0.33) PTPN1APPL3MBTL1HTR1BCYP1A2
SCHEMBL3656907 0.89 PTGS2 (0.34) APPL3MBTL1KMT2ARAB9APTGS2
SCHEMBL3659956 0.87 APP (0.33) APPL3MBTL1HTR1BTDP1HTR1D
SCHEMBL3662361 0.84 L3MBTL1 (0.35) PTPN1APPL3MBTL1KMT2AHTR1B
SCHEMBL3659801 0.83 L3MBTL1 (0.37) PTPN1APPL3MBTL1KMT2AHTR1B
SCHEMBL3662356 0.82 APP (0.34) APPL3MBTL1KMT2ANPC1RAB9A
SCHEMBL3663858 0.81 PTGS2 (0.36) PTPN1APPL3MBTL1KMT2AMEN1
SCHEMBL3664404 0.80 SMN1; SMN2 (0.34) PTPN1APPL3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed
EP-2215062-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME Sumitomo Chemical Company, Limited (JP) 2010-08-11 EP disclosed
WO-2009069792-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 PTPN1 4208/4885APP 2380/4885L3MBTL1 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.